» Articles » PMID: 23634229

Genetic Polymorphism of the Kinesin-like Protein KIF1B Gene and the Risk of Hepatocellular Carcinoma

Overview
Journal PLoS One
Date 2013 May 2
PMID 23634229
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Frequent deletions of the kinesin-like protein gene 1B (KIF1B) have been reported in neural tumors. Recently, a genome-wide association study revealed an association between polymorphisms in the KIF1B gene and the risk of hepatocellular carcinoma (HCC), and several case-control studies have further investigated this relationship. However, these studies have yielded controversial results. We therefore performed a meta-analysis to derive a more precise estimation of the association between the KIF1B gene polymorphisms and HCC risk.

Methodology/principal Finding: PubMed, EMBASE, the ISI Web of Science and the CNKI databases were systematically searched to identify relevant studies. A total of 5 studies containing 13 cohorts with 5,773 cases and 6,404 controls were included. Odds ratios (ORs) with corresponding 95% confidence intervals (CIs) were used to assess the strength of the associations. Subgroup analyses were conducted based on ethnicities, sample sizes and quality scores. Overall, the G allele at rs17401966 of the KIF1B gene was associated with a significantly decreased risk for HCC (OR = 0.81, 95%CI: 0.70-0.93; P = 0.003). Furthermore, subgroup analyses showed that the G allele at rs17401966 of the KIF1B gene significantly reduced the risk for HCC in Chinese cohorts (OR = 0.76, 95%CI: 0.64-0.90; P = 0.002), large-sample-size cohorts (OR = 0.80, 95%CI: 0.73-0.88, P<0.01) and high-quality cohorts (OR = 0.78, 95%CI: 0.71-0.87, P<0.01). However, no significant associations were found in small-sample-size cohorts, studies with low-quality scores and when excluding the cohorts from the study reporting the original discovery.

Conclusion/significance: These findings demonstrate that the presence of the G allele at rs17401966 of the KIF1B gene may decrease the risk for HCC and suggest that KIF1B may play a critical role in the development of HCC. High-quality studies with larger sample sizes and different ethnic populations will be of great value to further confirm these findings.

Citing Articles

The role of kinesin superfamily proteins in hepatocellular carcinoma.

Ghnim Z, Mahdi M, Ballal S, Chahar M, Verma R, Ali Al-Nuaimi A Med Oncol. 2024; 41(11):271.

PMID: 39400594 DOI: 10.1007/s12032-024-02497-0.


Exploring Hepatocellular Carcinoma Pathogenesis: The Influence of Genetic Polymorphisms.

Mollazadeh S, Saeedi N, Al-Asady A, Ghorbani E, Khazaei M, Ryzhikov M Curr Pharm Des. 2024; 31(6):432-442.

PMID: 39297458 DOI: 10.2174/0113816128327773240827062719.


The role of kinesin family members in hepatobiliary carcinomas: from bench to bedside.

Zhao K, Li X, Feng Y, Wang J, Yao W Biomark Res. 2024; 12(1):30.

PMID: 38433242 PMC: 10910842. DOI: 10.1186/s40364-024-00559-z.


USP9X promotes apoptosis in cholangiocarcinoma by modulation expression of KIF1Bβ via deubiquitinating EGLN3.

Chen W, Song J, Liu S, Tang B, Shen L, Zhu J J Biomed Sci. 2021; 28(1):44.

PMID: 34112167 PMC: 8191029. DOI: 10.1186/s12929-021-00738-2.


Association of a Novel Gene Polymorphism with Susceptibility to Schizophrenia and Breast Cancer: A Case-Control Study.

Sargazi S, Heidari Nia M, Mirinejad S, Moudi M, Jafari Shahroudi M, Saravani R Iran J Public Health. 2021; 50(2):397-406.

PMID: 33748005 PMC: 7956084. DOI: 10.18502/ijph.v50i2.5359.


References
1.
DerSimonian R, Laird N . Meta-analysis in clinical trials. Control Clin Trials. 1986; 7(3):177-88. DOI: 10.1016/0197-2456(86)90046-2. View

2.
Midorikawa Y, Yamamoto S, Tsuji S, Kamimura N, Ishikawa S, Igarashi H . Allelic imbalances and homozygous deletion on 8p23.2 for stepwise progression of hepatocarcinogenesis. Hepatology. 2008; 49(2):513-22. DOI: 10.1002/hep.22698. View

3.
Chen Y, Takita J, Chen Y, Yang H, Hanada R, Yamamoto K . Genomic structure and mutational analysis of the human KIF1Balpha gene located at 1p36.2 in neuroblastoma. Int J Oncol. 2003; 23(3):737-44. View

4.
El-Serag H . Epidemiology of viral hepatitis and hepatocellular carcinoma. Gastroenterology. 2012; 142(6):1264-1273.e1. PMC: 3338949. DOI: 10.1053/j.gastro.2011.12.061. View

5.
Nangaku M, Okada Y, Noda Y, Takemura R, Yamazaki H, Hirokawa N . KIF1B, a novel microtubule plus end-directed monomeric motor protein for transport of mitochondria. Cell. 1994; 79(7):1209-20. DOI: 10.1016/0092-8674(94)90012-4. View